Magazine Molecular Biology Pharma Companies Regulations 
Drug Discovery World
MAY 6, 2024
Mazzetti and Schneider give the example of T3 Pharmaceuticals, a University of Basel spin-off that developed a proprietary cancer therapy platform based on regulating and harnessing the natural behaviours of live bacteria. So, in this way there is a cross fertilisation from the bigger companies to newer ones.
Codon
FEBRUARY 13, 2024
doi: 10.2210/rcsb_pdb/goodsell-gallery-048 The Virus that Cures It’s been over 25 years since the science magazine Discover first ran an extraordinary article about how a long-forgotten medical treatment, used in the former Soviet country of Georgia, could save us from the growing threat of untreatable, drug-resistant infections.
Expert insights. Personalized for you.
147 
Let's personalize your content